Menu
Share on facebook
Share on twitter
Share on email
Share on facebook
Share on twitter
Share on email
Menu
Share on facebook
Share on twitter
Share on email
Menu
Menu
This GYA Working Group focuses on biodiversity conservation from a biomedical perspective. The aims are to preserve knowledge about the medicinal properties of different species, create a global knowledge hub for biodiversity and biomedicine, and develop new pharmaceuticals from nature while protecting biodiversity.
The loss of biodiversity minimises the potential for harvesting new medicines and for future medical discoveries. This is due to the interdependence of sustainability of the environment, human wellbeing, and the development of new public health practices. The actions of our group will mobilise the skills and expertise within the GYA to address this issue. In addition, the Bio2Bio incubator group aims to create practical recommendations for the sustainable use of Earth’s finite natural resources for healing purposes and requests the support from policymakers. With the expanding loss of biodiversity, we must act now to avoid losing new solutions for human-focused problems.
This activity is currently active.
Membership of GYA activities is reserved to current or former GYA members only, so please log in to view further information and options.
As a non-member, you can sign up for the monthly GYA newsletter by using the newsletter sign-up form at the very bottom of this page.
Active members – Active group members are current GYA members proactively participating in the group’s overall work and progress, by contributing to discussions or (text) outputs, or organising and running workshops and other (online) meetings.
Followers – Followers of a group are subscribers to the mailing list, but are not expected to actively contribute. Followers may be current members or alumni of the GYA.
Past Members – Past members are GYA members and alumni who have previously been active in the group. They are no longer included in group communications/mailing lists.
You are not logged in. Membership options are only available to members and alumni when logged in.
N/A
For GYA members and alumni only: connect to the group, collaborate and discuss with other members on the GYA-internal Agora platform here.
The group is working on forming a network of research activities (finding new lead compounds from indigenous species) and establishing a library of compounds.
2022
Ongoing projects:
In September 2022, Group co-leads Yensi Flores Buesco (University College Cork, Ireland) and Myrtani Pieri (University of Nicosia, Cyprus) conducted a number of activities at the University of Nicosia and in Nicosia, Cyprus. They gave a synthetic Biology in silico workshop to introduce students and lecturers of Cyprus universities to Synthetic biology principles and techniques. They also participated in the European Researcher’s Night and attended local events to inform on policy and society. Read the full report with detailed information about the activities here.
In late June, the “Bridging the Intangible in Science and Arts” session was jointly held by the “Science and Art = Peace and Justice” and “Biodiversity for Survival via Biomedicine” working groups in June in online format. It included the presentation of various Activity Groups projects, including “Protein Art” and “Poetry of Science”. Read the full report here.
In April, the group Co-leads met in Naples, Italy to work together on current projects.
August 2020 – A policy paper by several group members on “Towards policies that capture the expected value of biomolecular diversity for drug discovery, human health, and well‑being” has been published in Biologia Futura in August 2020 (open access). In the paper, the authors argue that there exists an urgent need to over-come economic, disciplinary, national, cultural, and regional barriers, in order to work out innovative measures to create a sustainable future and prevent the mutual extinction of humans and other species. The paper aims to help policy-makers with a characterization of the intrinsic value of biodiversity and its role as a critical foundation for sustainable development, human health, and well-being.
July 2020 – Several group members contributed to a publication on “Biodiversity and Biomedicine: Our Future” (published by Elsevier; behind a paywall). GYA alumni and former group co-leads Dilfuza Egamberdieva (National University of Uzbekistan, Uzbekistan) and Milica Pesic (University of Belgrade, Serbia) co-edited the book with Munir Ozturk from Turkey. The book examines the diverse connections between conserving Earth’s biodiversity and human healthcare, and provides a new outlook on Earth’s animal, plant, and fungi species as vital sources for human health treatments. While there are over 10 million various species on the planet, only 2 million have been discovered and named. This book identifies modern ways to incorporate Earth’s species into biomedical practices and emphasizes the need for biodiversity conservation.
April – Group members have published a paper on medicinal plant extracts in Acta Naurae.
January – The group have issued a call, with the support of the InterAcademy Partnership (IAP), for all IAP member academies to join its network aimed at protecting the molecular diversity needed for novel biomedical discoveries and development. This network aims to create an open, interdisciplinary, international collaborative platform for the exchange of data and knowledge on biodiversity. For details and on how to sign up to the initiative, please see the Call here.
October – Group members have published a paper on “Sharing digitized DNA sequences must balance scientific progress with fair use“.
September – The group organised a Scientific Symposium on Biodiversity and Biomedicine: Sustainability for Human Health within the World Social Science Forum in in Japan. See here for details.
Summer – The group has published a promotional video of their work, filmed by Nerina Finetto/ Traces.Dreams.
January – The group’s first position statement on the ‘Conservation of Biodiversity: Protecting Molecular Diversity and Biomedical Discoveries‘ has been released.
Several members from the Biodiversity group have been involved in the publication of an article titled “Bio2Bio Consortium: Biodiversity, Drug Discovery, and the Future of Global Health – introducing the Biodiversity to Biomedicine Consortium, a Call to Action” in the Journal of Global Health.
